Mental Health Does Not Discriminate
One of the most significant contributors to declining mental health is trauma. Trauma can take many forms, and its impact can be long-lasting and devastating.
The Duties of a Carer and the Hidden Costs of Care
Caring is an all-encompassing role that extends into financial, emotional, and physical realms. Carers provide essential support that enables disabled individuals to live with dignity, yet they often bear the brunt of financial strain. Recognizing and addressing these hidden costs is a step towards ensuring carers receive the support and financial security they deserve. Policymakers and support organizations must acknowledge that caring responsibilities do not pause simply because a disabled person is temporarily away from home.
Chronic Fatigue Syndrome (CFS) and PIP Eligibility
Chronic Fatigue Syndrome (CFS), also known as Myalgic Encephalomyelitis (ME), is a debilitating condition characterised by extreme and persistent fatigue that does not improve with rest. This condition affects individuals physically, mentally, and emotionally, significantly impacting their quality of life. For many, it can lead to a level of disability that makes them eligible for Personal Independence Payment (PIP) in the UK.
Comprehensive Guide On Neuropsychological Assessment for Multiple Sclerosis?
Multiple Sclerosis (MS) is a chronic, autoimmune condition that affects the central nervous system, potentially leading to a range of physical, emotional, and cognitive challenges. While much attention is often given to the physical symptoms of MS, such as mobility issues or fatigue, cognitive and emotional changes are also common but less understood. This is where neuropsychological assessments come into play.
Ocrevus and Its Link to Progressive Multifocal Leukoencephalopathy (PML)
Ocrevus Treatment For Multiple Sclerosis. Ocrevus, also known by its generic name ocrelizumab, is an immunotherapy drug commonly used to treat two types of multiple sclerosis (MS): relapsing-remitting multiple sclerosis …
Professor Neil Robertson: Leading Neurologist and Researcher
Professor Neil Robertson’s contributions to neurology and neurological research have not only advanced our understanding of complex disorders like multiple sclerosis but also shaped the landscape of neurological healthcare in Wales and beyond. His research and clinical work represent a commitment to both scientific discovery and compassionate care, offering hope to patients and families affected by neurological conditions. As he continues to lead new studies and mentor future neurologists, his impact will undoubtedly continue to be felt across the fields of neurology, genetics, and patient advocacy.
Progressive Multifocal Leukoencephalopathy (PML)
Progressive Multifocal Leukoencephalopathy (PML) is a severe, life-threatening condition that poses a particular risk for MS patients using immunosuppressive therapies. Awareness of the risk factors, regular monitoring, and open communication with healthcare providers are essential for MS patients considering or currently using these medications.
Taxpayer Survey: Re PIP Payments
The wide array of essential expenses that PIP covers for people with disabilities illustrates the importance of maintaining cash payments. A voucher-based system would struggle to address the individualized needs associated with disability-related costs, from specialized medical devices to unique dietary requirements.
Sun Therapy and Multiple Sclerosis
Research has shown that people living in regions farther from the equator, where there is less sunlight exposure, have a higher incidence of MS. This geographical distribution suggests a link between vitamin D deficiency and the risk of developing MS.
The Link Between Epstein-Barr virus, Location & MS
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system, leading to symptoms such as muscle weakness, coordination problems, and cognitive impairments.